CNS 2 Part 1 Flashcards

(41 cards)

1
Q

What is the 2nd most common neurodegenerative disease?

A

Parkinson’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which sex has a greater incidence of parkinson’s?

A

Men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do the motor features of Parkinson’s appear?

A

Typically start insidiously and emerge slowly over weeks or months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are not non-motor symptoms of Parkinson’s?

A

Depression, dementia, and hallucinations as well as autonomic, sensory, and REM sleep behavior disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two major neuropathologic findings of Parkinson’s?

A

Loss of pigmented dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies in the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Approximately how many of dopaminergic neurons are lost before the motor signs of Parkinson’s disease emergy?

A

60-80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the overall goal of medical managment of Parkinson disease?

A

Control signs and symptoms for as long as possible while minimizing adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the six main categories of pharmacologic treatment for parkinson’s disease?

A

Levodopa
Monoamine Oxidase- B inhibitors
Dopamine receptor agonists
Catechol-O- Methyl transferase inhibitory
Amantadine
Anticholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is Levodopa rarely used alone?

A

rarely used alone due to low bioavailability from a large first pass effect and significant adverse effects of nausea, anorexia, psychoses, and dyskinesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the pharmacodynamics of levodopa?

A

are that in restores the synaptic concentrations of dopamine by activating the post-synaptic dopamine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the wearing off and on off phenomenon associated with levodopa?

A

refers to a decrease in effectiveness at the of the drug’s dosing cycle resulting in periods of akinesia (no movement) or dyskinesia (unpredictable episodes of random movement) that occur with this drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can the wearing off and on off phenomenon be avoided in levodopa?

A

Improved with adding dopamine receptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the Monoamine oxidase (MAO)-B inhibitors drugs?

A

Rasagiline, selegiline, and safinamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When do MAO-B Inhibitors provide symptomatic benefit?

A

When used as monotherapy or as adjuncts to levodopa in early disease or in patient experiencing motor fluctuations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do MAO-B inhibitors work?

A

They inhibit the activity of MAO-B oxidases that are responsible for inactivating dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the adverse effects associated with MAO-B inhibitors?

A

extrapyramidal effects, insomnia, orthostatic hypotension, malignant hyperthermia if administered with meperidine, and hypertensive crisis.
Nausea and headache are the most common side effects associated with all the MAO-inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the two main types of Dopamine Receptor Agonists?

A

Ergot or non ergot derived

18
Q

How do Dopamine Receptor Agonists work?

A

exert their pharmacologic effect by directly activating dopamine receptors, bypassing the presynaptic synthesis of dopamine by the neurons in the substantia nigra

19
Q

What was the first dopamine receptor agonist to be developed?

A

Bromocriptine

20
Q

Which Dopamine Receptor Agonist is used as a rescue drug in patients experiencing sudden akinetic episodes that has more severe side effects?

A

Apomorphine

Side effects are: dyskinesias, drowsiness, sweating, hypotension)

21
Q

What are the adverse effects of Dopamine Receptor Agonists?

A

The main categories of adverse effects from the dopamine receptor agonists are GI, cardiovascular, dyskinesias similar as to occur with L-dopa, and mental disturbances including problems with impulse control resulting in compulsive gambling, shopping, betting, sexual activity, etc

22
Q

Which patients are ergot-derivatives are avoided in?

A

Patients with peripheral vascular disease

23
Q

What are the contraindications of dopamine agonists?

A

Psychotic illness or recent MI

24
Q

What are the main Catechol-O-Methyl Transferase Inhibitors (COMT-Inhibitors) drugs?

A

Tolcapone, entacapone, opicapone

25
Which COMT-Inhibitors is more potent with a longer duration of action?
Tolcapone
26
What are the adverse effects of COMT-Inhibitors?
Dyskinesias, confusion, sleep disturbances Orthostatic hypotension Diarrhea, abdominal pain, nausea Tolcapone: hepatotoxic- regulated use
27
What patients are the only one who can take COMT Inhibitors?
Only use for patients taking levodopa
28
What needs to be done for a patient to take Tolcapone?
They have to sign consent and LFT monitoring every 2 weeks during the first year
29
What is the mechanism of action of COMT Inhibitors?
Inhibit action of OMD that competes with L-dopa for active transport carrier
30
What is the mechanism of action of Amantadine?
the anti-viral treatment amantadine in the treatment of Parkinson's disease and drug-induced extrapyramidal reactions is uncertain
31
In which patients should amantadine not be used in?
should not be used in persons with pre-existing seizure disorder or psychiatric symptoms
32
What does amantadine increase the risk of?
Suicidal ideation
33
What are the two main anticholinergic agents?
Benzatropine-mesylate Trihexyphenidyl
34
What are the significant adverse effects of the anticholinergics?
Dry mouth, blurred vision, dizziness, constipation Anxiety, confusion, drowsiness
35
Who are anticholinergics not recommended for?
Anticholinergics
36
How should anticholinergics be discontinued and why?
should be performed gradually to avoid withdrawal symptoms that may manifest as an acute exacerbation of parkinsonism
37
How does Neuroprotection work in Parkinson's Disease?
Delays decline of motor symptoms and preserve quality of life
38
What is the initial treatment for antiparkinson agents?
MAO-B inhibitors [selegiline, rasagiline, safinamide] Indicated for mild symptoms
39
What is the treatment for patients with more severe symptoms?
begin treatment with Levodopa/Carbidopa or Dopamine Agonist
40
When do the wearing-off, on-off, or unpredictable-off effects start?
These motor complications occur in up to 90% of patients with PD within 5 to 10 years after the initiation of levodopa
41
How are the wearing-off, on-off, or unpredictable-off effects treated?
by using a dopamine agonist (pramipexole, ropinirole) by adding a COMT- inhibitor such as entacapone to decrease metabolism of levodopa and extend the levodopa effect adding an MAO-B inhibitor (selegiline, rasagiline, safinamide)